Arteriosclerosis
Not recruitingStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
- Disease:Arteriosclerosis
- Substances:Inclisiran
Slovakia- Participants:18–64 years · 65+ years
- Substances:Inclisiran
- Sponsor:Novartis Pharma AG
Rare diseases
Investigational molecules
Locations
Back to Slovakia115 clinical trials in Presov, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
Slovakia
SlovakiaThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on cardiovascular disease and metabolic conditions, investigating new treatments for heart conditions, stroke prevention, and diabetes management.
Multiple studies evaluating novel therapies for reducing cardiovascular events and improving patient outcomes.
Comprehensive research into chronic inflammatory conditions, with particular focus on Crohn's Disease and ulcerative colitis treatments.
Studies examining innovative biological therapies and their long-term effectiveness in treating autoimmune conditions.
Advanced research focusing on uncontrolled asthma and respiratory conditions, testing new therapeutic approaches for better disease control.
Clinical trials evaluating novel treatments to improve lung function and reduce asthma exacerbations.
Groundbreaking studies in cancer treatment, particularly focusing on prostate cancer and breast cancer therapies.
Investigating innovative treatment combinations and targeted therapies for better cancer management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.